584 related articles for article (PubMed ID: 8761942)
1. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
[TBL] [Abstract][Full Text] [Related]
2. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles.
Maeda S; Dean DD; Gay I; Schwartz Z; Boyan BD
J Bone Miner Res; 2001 Jul; 16(7):1281-90. PubMed ID: 11450704
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury.
Webb KE; Henney AM; Anglin S; Humphries SE; McEwan JR
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1837-44. PubMed ID: 9327785
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D3 regulation of stromelysin-1 (MMP-3) in chondrocyte cultures is mediated by protein kinase C.
Schmitz JP; Schwartz Z; Sylvia VL; Dean DD; Calderon F; Boyan BD
J Cell Physiol; 1996 Sep; 168(3):570-9. PubMed ID: 8816911
[TBL] [Abstract][Full Text] [Related]
5. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17F affects cartilage matrix turnover by increasing the expression of collagenases and stromelysin-1 and by decreasing the expression of their inhibitors and extracellular matrix components in chondrocytes.
Tanigawa S; Aida Y; Kawato T; Honda K; Nakayama G; Motohashi M; Suzuki N; Ochiai K; Matsumura H; Maeno M
Cytokine; 2011 Nov; 56(2):376-86. PubMed ID: 21885294
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D regulation of metalloproteinase activity in matrix vesicles.
Dean DD; Schwartz Z; Schmitz J; Muniz OE; Lu Y; Calderon F; Howell DS; Boyan BD
Connect Tissue Res; 1996; 35(1-4):331-6. PubMed ID: 9084672
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin fragments induce the expression of stromelysin-1 mRNA and protein in bovine chondrocytes in monolayer culture.
Bewsey KE; Wen C; Purple C; Homandberg GA
Biochim Biophys Acta; 1996 Oct; 1317(1):55-64. PubMed ID: 8876627
[TBL] [Abstract][Full Text] [Related]
9. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
11. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
Nguyen Q; Willenbrock F; Cockett MI; O'Shea M; Docherty AJ; Murphy G
Biochemistry; 1994 Mar; 33(8):2089-95. PubMed ID: 8117665
[TBL] [Abstract][Full Text] [Related]
12. Collagenase-1, stromelysin-1 and 92 kDa gelatinase are associated with tumor necrosis factor-alpha induced morphological change of human endothelial cells in vitro.
Nelimarkka LO; Nikkari ST; Ravanti LS; Kähäri VM; Järveläinen HT
Matrix Biol; 1998 Aug; 17(4):293-304. PubMed ID: 9749945
[TBL] [Abstract][Full Text] [Related]
13. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.
Gallegos NC; Smales C; Savage FJ; Hembry RM; Boulos PB
Surg Oncol; 1995; 4(2):111-9. PubMed ID: 7551259
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
Di Girolamo N; Lloyd A; McCluskey P; Filipic M; Wakefield D
Am J Pathol; 1997 Feb; 150(2):653-66. PubMed ID: 9033278
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and molecular characterization of stromelysin synthesized by human osteoarthritic chondrocytes stimulated with recombinant human interleukin-1.
Ganu VS; Hu SI; Melton R; Winter C; Goldberg VM; Haqqi TM; Malemud CJ
Clin Exp Rheumatol; 1994; 12(5):489-96. PubMed ID: 7531123
[TBL] [Abstract][Full Text] [Related]
16. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate.
Brown CC; Hembry RM; Reynolds JJ
J Bone Joint Surg Am; 1989 Apr; 71(4):580-93. PubMed ID: 2539384
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and their inhibitors regulate in vitro ureteric bud branching morphogenesis.
Pohl M; Sakurai H; Bush KT; Nigam SK
Am J Physiol Renal Physiol; 2000 Nov; 279(5):F891-900. PubMed ID: 11053050
[TBL] [Abstract][Full Text] [Related]
19. Matrix vesicles contain metalloproteinases that degrade proteoglycans.
Dean DD; Schwartz ZV; Muniz OE; Gomez R; Swain LD; Howell DS; Boyan BD
Bone Miner; 1992 May; 17(2):172-6. PubMed ID: 1611305
[TBL] [Abstract][Full Text] [Related]
20. Matrix vesicles are enriched in metalloproteinases that degrade proteoglycans.
Dean DD; Schwartz Z; Muniz OE; Gomez R; Swain LD; Howell DS; Boyan BD
Calcif Tissue Int; 1992 Apr; 50(4):342-9. PubMed ID: 1571846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
